SCHEMBL16628740

SCHEMBL16628740

CN(C)CCN(C)C(=O)c1nc(N)nc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 5/20 0.50
ADORA2A P29274 2/20 0.48
ADORA1 P30542 2/20 0.48
NUDT1 P36639 3/20 0.48
HSP90AA1 P07900 1/20 0.47
HSP90AB1 P08238 1/20 0.47
ALDH1A1 P00352 1/20 0.46
CYP1A2 P05177 1/20 0.46
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ATR Q13535 2/20 0.44
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
DCPS Q96C86 1/20 0.41
ADORA2B P29275 1/20 0.41
NCF1 P14598 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3096062 0.89 ADORA3 (0.50) ADORA3NUDT1HSP90AA1HSP90AB1ALDH1A1
SCHEMBL13144396 0.87 ADORA3 (0.48) ADORA3NUDT1HSP90AA1HSP90AB1ALDH1A1
SCHEMBL3094124 0.87 ADORA3 (0.48) ADORA3NUDT1HSP90AA1HSP90AB1ALDH1A1
SCHEMBL3087920 0.86 ADORA3 (0.52) ADORA3ADORA2AADORA1NUDT1HSP90AA1
SCHEMBL16628723 0.86 ADORA3 (0.51) ADORA3ADORA2AADORA1NUDT1HSP90AA1
SCHEMBL3093656 0.85 KMT2A (0.54) ADORA3ADORA2AADORA1NUDT1HSP90AA1
SCHEMBL3081057 0.84 CYP3A4 (0.53) ADORA3MEN1KMT2A
SCHEMBL13144400 0.84 MEN1 (0.60) ADORA3NUDT1MEN1KMT2A
SCHEMBL3075153 0.83 ADORA3 (0.57) ADORA3ADORA2ANUDT1HSP90AA1HSP90AB1
SCHEMBL3088200 0.83 NUDT1 (0.53) ADORA3ADORA2AADORA1NUDT1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP claimed
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP disclosed